ProteinQure
Our proprietary peptides can be used to deliver a variety of therapeutic payloads intracellularly via receptor-mediated endocytosis. Peptide-drug conjugates boast several advantages: they offer unique pharmacokinetics, and are significantly smaller than antibody-drug conjugates, which enables deeper tissue penetration and lower immunogenicity. Our platform integrates thousands of non-natural amino acids with high-quality in-house assays, enabling the design of unprecedented drug-like peptides fr
Basic Information
- Category: business
- Website: https://www.proteinqure.com
Documented Facts
- Email: team@proteinqure.com (No linked source recorded for this statement.)
Evidence and Sources
- ProteinQure — Official Site (official)
- ProteinQure on instagram (social)
- ProteinQure on facebook (social)
- ProteinQure on linkedin (social)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about ProteinQure.
- Canonical profile: https://brandsource.ai/brands/proteinqure
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/proteinqure/json-ld
- Citation profile API: https://brandsource.ai/api/brands/proteinqure/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (85/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Our proprietary peptides can be used to deliver a variety of therapeutic payloads intracellularly via receptor-mediated endocytosis. Peptide-drug conjugates boast several advantages: they offer unique pharmacokinetics, and are significantly smaller than antibody-drug conjugates, which enables deeper tissue penetration and lower immunogenicity. Our platform integrates thousands of non-natural amino acids with high-quality in-house assays, enabling the design of unprecedented drug-like peptides fr
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 3 supporting sources linked.
- 1 structured fact available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.